Erlotinib Suspended Phase 4 Trials for Metastatic Non-Small Cell Lung Cancer Treatment

IndicationsStatusPurposePhase
SuspendedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01320501Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer